Avanos Medical, Inc.
AVNS
$11.36
-$0.07-0.61%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.48% | 1.34% | 2.15% | -0.01% | -0.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.48% | 1.34% | 2.15% | -0.01% | -0.03% |
| Cost of Revenue | 6.04% | 5.35% | 4.39% | 3.13% | 3.86% |
| Gross Profit | -2.13% | -1.77% | 0.42% | -2.40% | -2.91% |
| SG&A Expenses | 0.90% | -3.53% | -3.26% | -7.66% | -7.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -113.95% | -47.83% | -9.09% | 0.00% | 16.22% |
| Total Operating Expenses | 2.33% | 0.26% | 0.20% | -2.70% | -2.66% |
| Operating Income | -11.19% | 21.45% | 56.41% | 64.71% | 67.58% |
| Income Before Tax | -3,508.57% | -14,733.33% | -5,005.06% | 1,144.00% | 37.25% |
| Income Tax Expenses | -327.14% | -446.51% | -950.00% | -49.43% | 337.50% |
| Earnings from Continuing Operations | -6,690.00% | -23,662.50% | -3,802.02% | 293.75% | -18.60% |
| Earnings from Discontinued Operations | -371.43% | 92.74% | 88.82% | 86.43% | 101.57% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6,115.58% | -518.33% | -534.47% | 128.34% | 121.39% |
| EBIT | -11.19% | 21.45% | 56.41% | 64.71% | 67.58% |
| EBITDA | -5.85% | 10.74% | 22.72% | 24.93% | 15.23% |
| EPS Basic | -6,091.07% | -530.36% | -546.92% | 128.82% | 121.93% |
| Normalized Basic EPS | -7.02% | 61.43% | 161.96% | 150.15% | 134.52% |
| EPS Diluted | -6,306.59% | -530.44% | -545.74% | 127.74% | 120.94% |
| Normalized Diluted EPS | -7.44% | 60.82% | 162.66% | 150.97% | 137.74% |
| Average Basic Shares Outstanding | -0.38% | -1.08% | -1.23% | -1.29% | -0.75% |
| Average Diluted Shares Outstanding | -0.38% | -0.64% | -0.64% | -0.53% | -0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |